What are the indications, preparation, sedation, and post‑procedure care for an upper gastrointestinal (upper GI) endoscopy in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Upper Gastrointestinal Endoscopy: Indications, Preparation, Sedation, and Post-Procedure Care

Upper GI endoscopy should be performed for patients over 45 with new or changed dyspeptic symptoms, those with alarm features (progressive dysphagia, haematemesis, anorexia, weight loss), and younger patients with H. pylori positivity or NSAID use who have persistent symptoms despite treatment. This age-based approach prioritizes early detection of gastric cancer, which accounts for over 10,000 deaths annually in England and Wales 1.

Appropriate Indications for Upper Endoscopy

High-Priority Indications (Perform Urgently)

  • Progressive dysphagia (97.6% physician consensus) 1
  • Haematemesis (99% physician consensus) 1
  • Patients over 60 years with anorexia, early satiety, or weight loss even with normal barium studies (87.2% consensus) 1
  • Any patient over age 45 with recent onset or change in dyspeptic symptoms 1

The rationale here is clear: these presentations carry significant risk for gastric malignancy, and delayed diagnosis directly impacts mortality. The age threshold of 45 reflects the epidemiology of gastric cancer in Western populations.

Standard Indications

  • Patients under 45 with dyspepsia who are H. pylori positive on non-invasive testing 1
  • Patients under 45 with dyspepsia taking NSAIDs 1
  • Dyspepsia persisting despite H2 antagonist therapy (96.8% consensus) 1
  • Patients requiring long-term acid suppression (H2 antagonists, PPIs, or prokinetic drugs) 1
  • Patients under 45 with severe, persistent symptoms unresponsive to treatment 1

Inappropriate Indications (Do Not Perform)

  • Typical irritable bowel syndrome symptoms without dyspepsia 1
  • Mild-to-moderate reflux responding to lifestyle modifications, antacids, or alginates 1
  • Known duodenal ulcer responding to treatment 1
  • Single episode of dyspepsia, now asymptomatic without treatment 1
  • Asymptomatic hiatus hernia on barium study (only 4.5% would endoscope) 1
  • Uncomplicated heartburn responding to treatment (only 5% would endoscope) 1

A critical pitfall: British guidelines emphasize earlier endoscopy compared to American approaches, which often defer until formal antiulcer treatment fails. The British panel would have identified gastric cancers that American criteria missed 1.

Pre-Procedure Preparation and Patient Evaluation

Essential Pre-Procedure Assessment

Obtain informed consent documenting risks, benefits, alternatives, sedation plan, and potential interventions before the procedure 2. This must be performed by the endoscopist, not delegated.

Pre-Endoscopy Questionnaire Components 3

Patients should complete a structured questionnaire addressing:

  1. General health status (excellent/good/fair/poor)

  2. Recent health changes

  3. Specific medical conditions:

    • Heart attack, heart failure, or cardiac insufficiency
    • Stroke
    • Lung problems (asthma, pneumonia, emphysema)
    • Liver disease or hepatitis
    • Hypertension
    • Diabetes
    • Bleeding disorders
    • Seizures
    • Rheumatic fever
  4. Complete medication list including ALL prescription and non-prescription drugs (aspirin, oral contraceptives) with dosages and frequency 3

  5. Allergies or sensitivities to medications or adhesive tape 3

  6. Personal or family history of anesthetic/sedation complications 3

Risk Stratification

Use the American Society of Anesthesiologists (ASA) classification 3:

  • ASA I: No organic disturbance; localized pathology only
  • ASA II: Mild-to-moderate systemic disturbance (controlled diabetes, mild heart disease, essential hypertension, anemia)
  • ASA III: Severe systemic disturbance
  • ASA IV: Life-threatening systemic disorders (marked cardiac insufficiency, persistent angina, active myocarditis)
  • ASA V: Moribund patient with little survival chance

Patients ASA III and above require enhanced monitoring and potentially anesthesiologist involvement.

Sedation and Monitoring

Equipment and Technique Standards

Use high-definition white-light endoscopy systems instead of standard-definition whenever possible 2. Document the specific endoscope model used 2.

Apply image enhancement technologies during examination to improve detection of preneoplasia and neoplasia 2. Suspicious areas require clear description, photodocumentation, and separate biopsies.

Patient Monitoring During Procedure

Pulse oximetry should be used for all "at-risk" patients (ASA III or higher), during difficult/prolonged procedures, emergency procedures, procedures using large-diameter instruments, procedures in darkened rooms (ERCP), and when using benzodiazepine/opioid combinations 3.

While routine monitoring equipment use lacks evidence for reducing morbidity/mortality, it detects clinically inapparent oxygen desaturation and alerts to patient deterioration 3. Monitoring must not distract from basic clinical observation 3.

Sedation Considerations

The evidence shows significant variability in sedation practices globally. A trained registered nurse can administer moderate sedation, monitor the patient, and assist with brief interruptible tasks 4. However, recommendations for propofol administration differ: British guidelines require anesthesiologist or second trained physician administration, while European and American societies permit nonanesthesiologist administration in selected patients 5.

Common pitfall: Over 50% of serious adverse reactions during endoscopy are cardiopulmonary, with frequent oxygen desaturation occurring during procedures 3. Most cardiac dysrhythmias result from hypoxia 3.

Post-Procedure Care

Immediate Recovery (Inpatients) 3

  1. Position patient lying on side; allow sleep up to 2 hours
  2. After 2 hours, sit patient up and offer sip of water
  3. If water swallowed without pain or coughing, allow full drink
  4. Report any pain or distress immediately to medical registrar; give nothing further by mouth until evaluated
  5. If water tolerated, resume normal diet
  6. Expect sore throat for 24-48 hours (normal finding)

Discharge Criteria and Instructions (Outpatients) 3

Mandatory requirements:

  • Patient must be accompanied home by responsible adult if discharged within 24 hours 3
  • Provide written discharge instructions 3

Specific 24-hour restrictions:

  • No driving or operating machinery 3
  • No alcohol consumption 3
  • Other fluids permitted; resume normal diet 3
  • Rest at home 3

Warning signs requiring immediate medical attention:

  • Severe pain in neck, chest, or abdomen 3

Documentation and Follow-Up 2

Document management recommendations based on specific findings (peptic ulcer disease, erosive esophagitis) in the medical record 2. If recommendations depend on histopathology (H. pylori, Barrett's esophagus), document that guidance will be provided after results are available 2.

Document whether surveillance endoscopy is needed and the appropriate interval 2.

Quality Measures 2

  • Ensure adequate mucosal visualization using cleansing and insufflation; document this 2
  • Spend sufficient time inspecting foregut mucosa in both anterograde and retroflexed views 2
  • Document abnormalities using established classifications and standard terminology 2
  • Perform biopsies using standardized protocols 2

Critical pitfall: Clinical monitoring must continue into the recovery period; non-invasive monitoring may be needed for select patients 3. The endoscopist must provide specific instructions to the qualified nurse responsible for patient recovery 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.